|
|||||
|
|
Pre/post effectiveness evaluation of updated additional risk minimisation measures for an orphan disease: Myozyme (alglucosidase alfa) Safety Information Packet |
|
| Authors: | Esther Artime Irene Shui Ignacio Mendez Stephanie Tcherny‐Lessenot Pierre D'Arbigny Noelia Alfaro Nawab Qizilbash |
| Abstract: | |
| Keywords: | educational materials effectiveness evaluation PASS pharmacoepidemiology risk minimisation survey |